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Smokers’ relative risk for aortic aneurysm
compared with other smoking-related diseases: A
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Objective: Aortic aneurysm has traditionally been considered a manifestation of atherosclerosis, but recent evidence
suggests an independent pathogenesis, possibly similar to that of chronic obstructive pulmonary disease (COPD).
Further insight into the pathogenesis of aortic aneurysm might be obtained by comparing its association with smoking
with that of other smoking-related diseases.
Study design:We conducted a systematic review of studies providing relative risk associated with smoking for both aortic
aneurysm and other smoking-related diseases.
Results: We identified 10 eligible studies, which included more than 3 million subjects. The events reported in 9 studies
were death from target diseases; the tenth study reported new diagnoses. Relative risk for aortic aneurysm-related events
in current smokers was generally 3 to 6, compared with 1 to 2 for coronary artery disease or cerebrovascular disease and
5 to 12 for COPD. For each category of smoking in each study, relative risk associated with smoking was substantially
greater for aortic aneurysm than for coronary artery disease or cerebrovascular disease. Our pooled estimates indicate
that, in men, the association of ever smoking with aortic aneurysm is 2.5 times greater than the association of ever
smoking with coronary artery disease (95% confidence interval [CI], 2.2, 2.8) and 3.5 times greater than the association
of ever smoking with cerebrovascular disease (95% CI, 2.4, 5.3), but only 0.56 as great as the association of ever smoking
with COPD (95% CI, 0.36, 0.86).
Conclusions:The difference in magnitude of these associations with smoking is consistent with a non-atherosclerotic cause
for aortic aneurysm and/or a stronger effect of smoking on vascular disease in the peripheral arteries. (J Vasc Surg 2003;
38:329-34.)
Aortic aneurysms that are not associated with a specific
cause (such as syphilis or Marfan syndrome) have tradition-
ally been attributed to atherosclerosis.1-6 However, various
lines of evidence have led some investigators to propose
that aortic aneurysm is a distinct pathophysiologic entity.1-
3,5,6 Several studies have suggested a mechanism of aortic
aneurysm development involving connective tissue degen-
eration mediated by matrix metalloproteinases, similar to
pathophysiology proposed for chronic obstructive pulmo-
nary disease (COPD).7,8 Smoking is an important risk
factor for aortic aneurysm, atherosclerosis, and COPD, and
the shared risk factor of smoking has been considered
evidence in favor of the traditional view that aortic aneu-
rysm is a manifestation of atherosclerosis.2,4-6
The association between smoking and aortic aneurysm
was first reported by Hammond and Horn9 in 1958. These
authors contrasted the strong association they observed
between smoking and aortic aneurysm with the more mod-
erate association they found between smoking and coro-
nary disease or cerebral vascular disease. Though numerous
subsequent articles have confirmed the association between
smoking and aortic aneurysm, to our knowledge none have
revisited the relative strengths of these associations.
Further insight into the cause of aortic aneurysm might
be gained from closer examination of the pattern of smok-
ers’ risk for aortic aneurysm and other smoking-related
diseases. We therefore sought to determine whether the
difference in the association with smoking observed by
Hammond and Horn between aortic aneurysm and occlu-
sive vascular disease was generally present in other studies.
We conducted a systematic review of studies reporting
relative risk associated with smoking for both aortic aneu-
rysm and the four major smoking-related diseases, ie, cor-
onary artery disease, cerebrovascular disease, COPD, and
lung cancer.
METHODS
We searched MEDLINE for 1966 to October 2002 for
studies in English performed in human beings, using the
search strategies “smoking” with subheading “mortality,”
“smoking and mortality,” and “smoking and aortic aneu-
rysm.” All individual categories were exploded, and all but
“aortic aneurysm” were restricted to focus. The titles and
abstracts of the resulting 504 references were reviewed by
one of us (F.L.). Articles were obtained for all abstracts with
potentially includable data, and these, plus articles in our
files and references cited in these articles, were reviewed by
one of us (F.L.). All articles that provided relative risk
associated with smoking for both aortic aneurysm and at
least one other smoking-related disease were included if
there were at least 25 aortic aneurysm events.
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Data were extracted from each study on events, cate-
gorized by smoking status, that were attributed to aortic
aneurysm, coronary artery disease, cerebrovascular disease,
COPD, or lung cancer. Whenever possible, we selected
smoking status data categorized as “never,” “current,” or
“former” cigarette smokers and ignored (or combined)
subgroups relating to factors such as smoking quantity and
types of cigarette. Studies that reported aortic aneurysm
events only in combination with other events in a broader
category such as “Other cardiovascular diseases” could not
be included without obtaining separate aortic aneurysm
data from the original investigators. We requested these
separate data on aortic aneurysm from four large studies
that had not published them previously, primarily to inves-
tigate publication bias, ie, the possibility that aortic aneu-
rysm data were more likely to have been displayed sepa-
rately when the association with smoking was strong. The
requested data were no longer available from 1 of these
studies,10 but were received from the other 3 studies,11-13
which were then included in our analysis.
Pooled estimates were generated as described by Der-
Simonian and Laird14 from raw numbers of subjects and
deaths in each smoking category. These were obtained
from the cited publications, previous study publications,
backcalculation from other published data, or directly from
the authors. We did not have access to data for individual
subjects, so were unable to use person-years or age-adjust-
ment in our pooled estimates, resulting in some differences
between data we used for pooling and relative risk calcu-
lated by the original authors.
Heterogeneity between studies was assessed with the 2
test.14 Test results positive for heterogeneity were consid-
ered an indication for using random effect models to gen-
erate pooled estimates and confidence intervals.
Because we were primarily interested in relationships
between relative risk rather than in relative risks itself, we
pooled ratios of relative risk. For example, we divided
relative risk in ever smokers for death from aortic aneurysm
by relative risk in ever smokers for death from coronary
artery disease for each study, and pooled these results to
obtain an overall estimate of this ratio. Differences for
which the 95% CI do not include 1 are significant at the .05
level.
RESULTS
Studies that met our inclusion criteria are shown in
Tables I and II, which also include the 3 studies that did not
report aortic aneurysm data separately in their original
publications but provided us with this information.11-13
These 10 studies included more than 3 million subjects. All
studies followed the same format of recording smoking
status at an index time, or, in the case of 1 study,15 at several
times, and then recording subsequent events. Smoking
status therefore reflects the beginning of the follow-up
period and not necessarily the time when the event oc-
curred. The events reported were cause of death recorded
on the death certificate in all studies except 1, which used a
new diagnosis of the respective disease as the event of
interest.16 Relative risk shown was based on persons or
person-years, as reported by the original authors.











Hammond and Horn9 187,783 50-69 Healthy acquaintances of volunteer recruiters 3.7 90
CPS-I12,30 440,558 35-84 Residents of 25 US states (tended to be
white, married, educated)
6 396
CPS-II† 508,351 30 Same as CPS-I, but all 50 states 14 1276
Rogot and Murruy22 248,046 31-84 US veterans with government life insurance 16 1318
Weir and Dunn31 68,153 35-64 California labor union members 5-8 51
Doll et al15 34,439 35 British physicians 40 331
Nilsson et al32 16,458 18-69 Random sample of Swedish population 33 106
Tang et al13‡ 56,255 35-78 Combines four British studies with
enrollment by occupation or locality
10-20 143
MRFIT§ 361,662 35-57 Volunteers from 18 US cities 15-17 423
Goldberg et al16 2,710 55-64 Japanese Hawaiians without previous
diagnoses of end points
20 119
Women
CPS-I12,30 562,671 35-84 Residents of 25 US states (tended to be
white, married, educated)
6 153
CPS-II† 676,306 30 Same as CPS-I, but all 50 states 14 604
Nilsson et al32 25,086 18-69 Random sample of Swedish population 33 90
CPS, Cancer Prevention Study; MRFIT, Multiple Risk Factor Intervention Trial.
*Events were deaths in all studies except that of Goldberg et al,16 in which diagnoses were used.
†American Cancer Society, unpublished 14-year follow-up data, 1999.
‡Unpublished aortic aneurysm data provided by NJ Wald, 1999. This study combines data from the British United Provident Association (BUPA) study,
Whitehall study, Paisley-Renfrew study, and United Kingdom Heart Disease Prevention Project.
§Neaton JD, Svendsen K, unpublished data, 1999.
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Relative risk tended to be substantially higher for cur-
rent smokers than for former smokers, especially risk for
aortic aneurysm, COPD, and lung cancer. For every study,
association with smoking was substantially greater for aortic
aneurysm than for coronary artery disease or cerebrovascu-
lar disease. Relative risk for aortic aneurysm in current
smokers was generally 3 to 6, compared with 1 to 2 for
coronary artery disease and cerebrovascular disease. The
association with smoking was generally substantially less for
aortic aneurysm than for COPD or lung cancer.
Pooled estimates of smokers’ relative risk for death
from aortic aneurysm divided by smokers’ relative risk for
death from each of the other smoking-related diseases are
presented in Table III. Heterogeneity between studies was
significant in nearly all of the categories shown; thus all
pooled estimates were obtained from random effects mod-
els.14 For men, the association of ever smoking with aortic
aneurysm was 2.5 times greater than the association of ever
smoking with coronary artery disease (95% CI, 2.2, 2.8)
and 3.5 times greater than the association of ever smoking
with cerebrovascular disease (95% CI, 2.4, 5.3), but only
0.56 as great as the association of ever smoking with COPD
(95% CI, 0.36, 0.86) (Table III).
DISCUSSION
The results of our systematic review indicate that the
association between smoking and aortic aneurysm is sub-
stantially stronger than the association between smoking
and coronary or cerebral vascular disease. This relationship
was seen in every study and in nearly every group of
smokers, and was equally true of studies that did not show
aortic aneurysm results separately in their original publica-
tion, indicating no evidence of publication bias. Our
pooled estimates show that smoking increases risk for death
from aortic aneurysm more than twice as much as it in-
creases risk for death from coronary disease or cerebral
vascular disease. COPD and lung cancer are even more
strongly associated with smoking.
Although the shared risk factor of smoking has been
considered evidence for a common cause for occlusive
vascular disease and aortic aneurysm,2,4-6 the difference in
strength of the smoking association we have demonstrated
Table II. Smokers’ relative risks for aortic aneurysm and other smoking-related diseases, as determined by original
authors
Study Category of smoker*











Hammond and Horn9 Ever 2.7 1.7 1.3 — 11.0
CPS-I12,30 Former 2.4 1.4 0.96 10.0 5.0
Current 4.1 1.8 1.4 8.8 11.0
CPS-II‡ Former 2.4 1.4 1.1 7.7 6.9
Current 6.0 2.0 1.8 18.0 23.0
Rogot and Murray22 Former 2.6 1.2 1.0 5.2 4.0
Current 5.2 1.6 1.3 12.0 11.0
Weir and Dunn31 Ever 2.6 1.6 1.2 12.0 7.6
Doll et al15 Former 2.2 1.5 1.1 5.7 4.1
Current 4.1 1.6 1.3 13.0 15.0
Nilsson et al32 Former 1.6 1.1 1.1 1.9 1.5
Current 3.3 1.4 0.99 6.8 9.4
Tang et al13§ Former 1.8 1.2 1.0 2.2 3.2
Current, plain 8.5 2.1 2.0 6.8 14.0
Current, filtered 7.4 1.9 1.6 6.4 13.0
MRFIT Current 3.1 1.9 2.0 4.7 5.8
Goldberg et al16 Current, 20 cigarettes/d 2.5 1.7 2.1 — —
Current, 20 cigarettes/d 3.4 2.1 2.4 — —
Current, 20 cigarettes/d 3.6 2.3 2.1 — —
Women
CPS-I12,30 Ever 3.7 1.4 1.3 5.9 2.6
CPS-II‡ Former 1.8 1.1 1.1 6.2 4.0
Current 6.9 1.9 2.0 17.0 15.0
Nilsson et al32 Former 0.42 1.2 0.85 1.6 0.97
Current 3.4 1.6 1.0 7.2 4.9
COPD, Chronic obstructive pulmonary disease; CPS, Cancer Prevention Study; MRFIT, Multiple Risk Factor Intervention Trial.
*Categories pertain to beginning of follow-up.
†Except MRFIT, for which comparison group includes both former smokers and never smokers.
‡American Cancer Society, unpublished 14 year follow-up data, 1999.
§Unpublished aortic aneurysm data provided by Wald NJ, 1999.
Neaton JD, Svendsen K, unpublished data, 1999.
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raises doubt regarding this interpretation. Relative strength
of association with smoking reflects cause in at least some
instances. Coronary and cerebral vascular disease, which are
atherosclerotic conditions, have associations with smoking
that are similar to each other and quite different from those
of COPD and lung cancer, which are non-atherosclerotic
conditions. The case for aortic aneurysm as a manifestation
of atherosclerosis would clearly be stronger if the associa-
tion of smoking with aortic aneurysm was similar in mag-
nitude to the association of smoking with coronary and
cerebral vascular disease.
The Aneurysm Detection and Management (ADAM)
screening study found aortic aneurysm to be much more
closely associated with smoking than with occlusive vascu-
lar disease.17 That study provides a different perspective
from the studies included in our analysis, because it re-
ported association with abdominal aortic aneurysm (AAA)
rather than association with smoking. In ADAM, the mul-
tivariable model for AAA 4.0 cm or greater in diameter
yielded odds ratios of 5.1 for ever smoking, 1.5 for coro-
nary artery disease, and 1.3 for cerebrovascular disease. The
ADAM findings, together with those of our systematic
review, suggest that smoking and aortic aneurysm are
linked much more closely to each other than either is to
coronary or cerebral vascular disease.
That the effect of smoking varies for different diseases
was evident from the earliest studies, reported in the 1950s.
Hammond and Horn9 noted that the association with
smoking was extremely high for lung cancer, somewhat less
but still very high for aortic aneurysm, and high to moder-
ate for coronary artery disease and cerebrovascular disease.
However, the reasons for these differences and their impli-
cations regarding pathophysiology remain unclear. Smok-
ing may promote coronary and cerebral vascular disease
through a variety of mechanisms, including an adverse
effect on lipids, endothelial damage, hemodynamic stress,
oxidant injury, enhanced thrombosis, and increased blood
viscosity.18 Aortic aneurysm develops through a degenera-
tive process involving the elastin and collagen of the arterial
media.7 There is some evidence that this process is medi-
ated by matrix metalloproteinases released by macro-
phages, and smoking may induce matrix metalloproteinase
production by macrophages.7,8 A similar mechanism has
been proposed for development of COPD.7,8 Aortic aneu-
rysm is associated with COPD, but this association appears
to be mediated through smoking and is not apparent after
adjustment for smoking,17,19,20 whereas atherosclerosis
and aortic aneurysm have a modest independent associa-
tion, as noted in the ADAM study. Further studies will be
needed to determine the true etiologic relationship among
these smoking-related diseases.
In addition to these differences in pathophysiology, the
traditional view that aortic aneurysm is a manifestation of
atherosclerosis has also been challenged for other rea-
sons3,5: aortic aneurysm is not found primarily in patients
with the most severe systemic or aortic occlusive disease;
aortic aneurysm occurs later in life than does occlusive
disease, and has a much greater male predominance com-
pared with occlusive disease; unlike occlusive disease, the
incidence of aortic aneurysm has not declined in recent
decades; aortic aneurysm is often familial and occurs in
genetic diseases (eg, Marfan disease) unrelated to occlusive
disease; and, unlike occlusive disease, aortic aneurysm is not
more common in patients with diabetes mellitus.15,23 Most
studies, eg, the ADAM study, indicate some association
between atherosclerosis and aortic aneurysm,17,19 but this
association does not appear to be strong enough to support
the inference that these are manifestations of the same
disease.
Table III. Pooled estimates of smokers’ relative risk for death from aortic aneurysm divided by smokers’ relative risk for
death from other smoking-related diseases












Ever vs never 2.5 (2.2, 2.8)‡ 3.5 (2.4, 5.3)‡ 0.56 (.36, .86)‡ 0.38 (.29, .50)‡
Current vs never 3.0 (2.5, 3.4)‡ 4.7 (3.1, 7.2)‡ 0.62 (.40, .98)§ 0.34 (.23, .49)‡
Current vs not current† 2.0 (1.7, 2.3)‡ 2.7 (1.9, 3.8)‡ 0.93 (.75, 1.1) 0.54 (.47, .62)‡
Women
Ever vs never 2.5 (1.7, 3.6)‡ 2.8 (2.0, 3.8)‡ 0.39 (.33, .47)‡ 0.36 (.31, .43)‡
Current vs never 3.0 (2.0, 4.6)‡ 3.5 (2.4, 5.2)‡ 0.43 (.36, .52)‡ 0.37 (.31, .43)‡
Current vs not current† 2.9 (2.1, 4.0)‡ 3.3 (2.4, 4.5)‡ 0.58 (.40, .83) 0.51 (.44, .59)‡
Numbers in parentheses represent 95% confidence interval.
COPD, Chronic obstructive pulmonary disease.
*Pooled estimates were obtained from studies listed in Table II, except for two studies that were excluded, one because it reported new diagnoses rather than
death, 16 and the other because number of deaths in each smoking category was not available.15 Estimates shown are from random effects models.14
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The results of our systematic review do not exclude the
possibility that smoking may simply promote atherosclero-
sis more effectively in large peripheral arteries than in the
coronary or cerebral arteries. Inclusion of peripheral arterial
occlusive disease (PAOD) in our study would have been of
interest in this regard. However, all but one of the studies
included in our analysis were based on deaths, and PAOD is
rarely a cause of death.21 The only study included in our
analysis that reported PAOD-related deaths separately con-
tained an insufficient number for analysis: 22, compared
with 1318 aortic aneurysm–related deaths.22 However, the
study based on new diagnoses rather than death16 did
report PAOD diagnoses in a later publication.23 The odds
ratio for PAOD obtained for smokers was 2.9, similar to
smokers’ relative risk of 2.5 to 3.6 reported for AAA in that
study (Table II). Other population-based prospective and
cross-sectional studies of smokers’ risk for PAOD have
obtained odds ratios in the range of 2 to 4,24-27 stronger
than smokers’ relative risk for coronary or cerebral vascular
disease but somewhat weaker than smokers’ relative risk for
AAA (Table II). Fowkes et al26 speculated that the greater
effect of smoking on atherosclerosis in the peripheral arter-
ies may be due to differences in arterial anatomy and
hemodynamics resulting in differences in smoking-induced
blood stagnation.
Other limitations of our analysis result from the
nature of the data available in the original studies,
though these studies form the basis of our knowledge of
the hazards of smoking, and data from one of them, the
Cancer Prevention Study II, are used by the US govern-
ment to calculate deaths attributable to smoking.28 Each
patient was assigned a single cause of death in the
mortality studies, and coexisting diseases were not con-
sidered. Cause of death was based on death certificates,
which may often be inaccurate.29 Furthermore, in most
studies the relative risk of smokers for the various dis-
eases were adjusted only for age. However, further ad-
justment beyond age did not substantially alter the re-
sults of the Cancer Prevention Study II.30 There were
also substantial differences between studies in partici-
pants, year of onset, and duration of follow-up, which
could be considered arguments against data pooling.
However, all of these studies provide pertinent informa-
tion on the relationship between these conditions, and
despite their differences, all showed similar findings re-
garding relative strengths of the smoking association.
In summary, data from large studies of smoking-related
outcomes consistently demonstrate an association between
smoking and aortic aneurysm that is substantially stronger
than the association between smoking and coronary disease
or cerebral vascular disease, but not so strong as the asso-
ciation between smoking and COPD or lung cancer. The
difference in magnitude of these associations suggest a
non-atherosclerotic cause for aortic aneurysm and/or a
stronger effect of smoking on vascular disease in the periph-
eral arteries.
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